Published in Vaccine Weekly, October 20th, 2004
The funding is renewable for up to 3 years. Aeras has received major funding from the Bill & Melinda Gates Foundation, but the cooperative agreement with CDC marks the first government contribution to Aeras.
"We look forward to working with the CDC to rapidly move promising vaccine candidates into clinical trials," said Aeras CEO Jerald Sadoff. "This critical support from the U.S. government marks...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly